NATURAL ALTERNATIVES INTERNATIONAL INC Logo

NATURAL ALTERNATIVES INTERNATIONAL INC

A science-based formulator and contract manufacturer of private-label nutritional supplements.

NAII | US

Overview

Corporate Details

ISIN(s):
US6388423021
LEI:
Country:
United States of America
Address:
1535 FARADAY AVENUE, CARLSBAD
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Natural Alternatives International, Inc. (NAI) is a leading formulator and custom contract manufacturer of nutritional supplements. Founded in 1980, the company provides a comprehensive range of private-label services, including custom formulation, manufacturing, quality assurance testing, finished goods packaging, and warehousing. NAI utilizes a science-based partnership approach to help clients design, produce, and market safe and effective vitamins, minerals, herbs, and other nutritional products for the international market. This focus on scientific guidance allows clients to differentiate their brands while ensuring product efficacy and safety.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NATURAL ALTERNATIVES INTERNATIONAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NATURAL ALTERNATIVES INTERNATIONAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NATURAL ALTERNATIVES INTERNATIONAL INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.